- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02865603
Impact of PAX Good Behavior Game on Elementary School Students in Estonia (PAXGBGEE)
November 1, 2018 updated by: Karin Streimann, National Institute for Health Development, Estonia
Effectiveness of a Universal Classroom-based Preventive Intervention (PAX GBG) in Estonia: A Matched-pair Cluster-randomized Controlled Trial
The aim of this study is to measure the impact of the intervention (PAX GBG) in Estonian-language 1st grade classrooms on students' mental health and behaviour, and teacher's self-efficacy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
2-year, matched-pair, cluster-randomized controlled trial with a intervention and wait-list control arm is conducted during school years 2016/17 and 2017/18.
42 volunteering schools were matched to pairs.
One school in each pair was randomly selected to receive the PAX GBG or continue their normal activities without intervention.
After a post-test assessment in spring 2018 the control group teachers are trained and supported to implement PAX GBG.
Study Type
Interventional
Enrollment (Actual)
708
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 8 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
All schools with first grade classrooms and Estonian-language as instruction language in Estonia were qualified to take part of the study if they did fit the inclusion criteria.
Schools were suitable to participate if they:
- Had equal to or more than 13 pupils in the first grade classroom in 2016/17 school term;
- Did not implement any other evidence-based program in basic school stage 1 (grades 1-3), (for example KiVa bullying prevention program);
- Did not already implement PAX GBG;
- Had at least one first grade teacher who volunteers to participate for the whole study period of two years.
Exclusion Criteria:
- Schools for children with special educational needs and schools with Russian language as instruction language were excluded.
- Schools with single-sex classrooms were excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PAX Good Behavior Game
The intervention is delivered by teachers within the normal school curriculum.
Teachers from intervention classes completed 3-day training and were supported by the mentor, who visited their class during the 2016/17 school year and provided counseling via e-mail and phone.
During the second year (2017/18) teachers could use the PAX GBG methods, but they did not receive additional support from the mentors.
|
PAX GBG includes evidence-based kernels and a classroom game where students are reinforced for their mutual success in withholding inappropriate behavior.
|
|
No Intervention: Waitlist control group
Control group continue their normal activities without intervention.
After a post-test assessment in spring 2018 the control group teachers will be trained and supported to implement PAX GBG.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in children's social and emotional well-being
Time Frame: Baseline, 7 months post-baseline and 19 months post-baseline
|
Children's social and emotional well-being will be measured by the teacher-completed Strengths and Difficulties Questionnaire with impact supplement (SDQ; Goodman, 1999) and parent-rated Strengths and Difficulties Questionnaire (Goodman, 1997).
|
Baseline, 7 months post-baseline and 19 months post-baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in symptoms of attention deficit hyperactivity disorder (ADHD) among the children
Time Frame: Baseline, 7 months post-baseline and 19 months post-baseline
|
The Swanson, Nolan and Pelham-IV Questionnaire (SNAP-IV) (Swanson et al., 2001) is an 18-item instrument for rating ADHD-related symptoms and will be completed by parents.
|
Baseline, 7 months post-baseline and 19 months post-baseline
|
|
Change in children's behavioral inhibition
Time Frame: Baseline, 7 months post-baseline
|
The effects of the intervention on inhibitory control will be measured using cognitive task (Go/No-Go task).
The task will be developed specially for this research and completed by children.
|
Baseline, 7 months post-baseline
|
|
Change in teachers' sense of efficacy
Time Frame: Baseline, 7 months post-baseline and 19 months post-baseline
|
Teachers' efficacy will be measured with The Teachers' Sense of Efficacy Scale (TSES; Tschannen-Moran & Hoy, 2001).
It is a self-reported measure for teachers that consists of 24 items and assesses the teacher's perception of their sense of effectiveness as a teacher.
|
Baseline, 7 months post-baseline and 19 months post-baseline
|
|
Change in classroom behavior
Time Frame: Baseline, 7 months post-baseline and 19 months post-baseline
|
Teacher-rated 4-item measure will be used to assess classroom behavior.
The measure originates from Organisation for Economic Co-operation and Development (OECD) Teaching and Learning International Survey (TALIS) 2013 teacher's questionnaire (question nr 41) and asks to indicate how strongly does the teacher agree or disagree with statements about the classroom behavior.
|
Baseline, 7 months post-baseline and 19 months post-baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Karin Streimann, National Institute for Health Development
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Streimann K, Selart A, Trummal A. Effectiveness of a Universal, Classroom-Based Preventive Intervention (PAX GBG) in Estonia: a Cluster-Randomized Controlled Trial. Prev Sci. 2020 Feb;21(2):234-244. doi: 10.1007/s11121-019-01050-0.
- Streimann K, Trummal A, Klandorf K, Akkermann K, Sisask M, Toros K, Selart A. Effectiveness of a universal classroom-based preventive intervention (PAX GBG): A research protocol for a matched-pair cluster-randomized controlled trial. Contemp Clin Trials Commun. 2017 Aug 30;8:75-84. doi: 10.1016/j.conctc.2017.08.013. eCollection 2017 Dec.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2016
Primary Completion (Actual)
June 1, 2018
Study Completion (Actual)
June 1, 2018
Study Registration Dates
First Submitted
August 4, 2016
First Submitted That Met QC Criteria
August 11, 2016
First Posted (Estimate)
August 12, 2016
Study Record Updates
Last Update Posted (Actual)
November 2, 2018
Last Update Submitted That Met QC Criteria
November 1, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- T90-C305
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Disorders
-
Rutgers, The State University of New JerseyRecruiting
-
Virginia Commonwealth UniversityCompletedMental Health DisordersUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMental Health DisordersCongo
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedMental Health DisordersNorway
-
York UniversityCanadian Institutes of Health Research (CIHR); North York General HospitalCompletedMental Health DisordersCanada
-
Kansas State UniversityAugusta University; Dartmouth College; University of CincinnatiEnrolling by invitationMental Disorders, Severe | Mental Illness PersistentUnited States
-
VA Boston Healthcare SystemUS Department of Veterans AffairsCompletedMental Health DisordersUnited States
-
University of ManchesterEuropean Research CouncilRecruitingMental Disorders, SevereUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...CompletedMental Disorders, SevereSpain
-
University of North Carolina, Chapel HillU.S. Department of JusticeCompletedMental Disorders, SevereUnited States
Clinical Trials on PAX Good Behavior Game
-
Linnaeus UniversityKarolinska Institutet; Uppsala University; Stockholm University; KTH Royal Institute... and other collaboratorsRecruitingWell-being in Elementary School Children | Mental Health in Elementary School Children | Work-related Stress in Teachers | Academic Performance in Elementary School ChildrenSweden
-
Region SkaneLund UniversityCompleted
-
Philipps University Marburg Medical CenterProf. Dr. Andreas Bechdolf (Chair of hospital), Vivantes Hospital Am Urban... and other collaboratorsCompletedEmotional Distress | Delusions | Self Esteem | Early PsychosisGermany
-
Universidade Federal de GoiasCompleted
-
Brightlobe LimitedRecruitingNeurodevelopmental Disorders | Autism Spectrum Disorder | Attention Deficit Hyperactivity Disorder | Dyslexia | Child Development | Specific Learning DisorderUnited Kingdom
-
Kocaeli UniversityNot yet recruitingDefecation DisorderTurkey (Türkiye)
-
Kos PharmaceuticalsCompletedStroke | Diabetes | Atherosclerosis | Dyslipidemia | Coronary Heart Disease